907 results on '"van Ingen, Jakko"'
Search Results
2. Real-World Patients’ Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey
3. Clinical presentation, management, and outcome of suspected central nervous system infections in Indonesia: a prospective cohort study
4. Incidence and clinical significance of non-tuberculous mycobacteria among migrants in Denmark: A nationwide register-based cohort study from 1991 through 2021
5. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease
6. ddPCR enables rapid detection of bloodstream infections in patients on home parenteral nutrition: A prospective cohort study
7. Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial
8. Non-tuberculous mycobacteria disease pre-lung transplantation: A systematic review of the treatment regimens and duration pre- and post-transplant.
9. Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis
10. Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution
11. Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands
12. The impact of BCG dose and revaccination on trained immunity
13. Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps
14. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review
15. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases
16. Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion
17. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification
18. Clinical characteristics and an evaluation of predictors for a favourable outcome of Mycobacterium abscessus otomastoiditis: a systematic review and meta-analysis of individual participant data
19. Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.
20. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children
21. Risk factors for nontuberculous mycobacterial pulmonary disease (NTM-PD) in Croatia
22. Dissemination of Mycobacterium abscessus via global transmission networks
23. Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
24. Challenging the gold standard: the limitations of molecular assays for detection of Mycobacterium tuberculosis heteroresistance.
25. Drug Susceptibility Testing of Nontuberculous Mycobacteria
26. Recovery of aerobic gram-negative bacteria from the Copan Eswab transport system after long-term storage
27. All you want to know about Mycobacterium abscessus
28. Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model
29. Outbreaks of healthcare-associated infections linked to water-containing hospital equipment: a literature review
30. Species Distribution and Isolation Frequency of Nontuberculous Mycobacteria, Uruguay
31. Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections
32. The stability of antimycobacterial drugs in media used for drug susceptibility testing
33. Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis—An ESGMYC collaborative study.
34. Successful addition of topical antibiotic treatment after surgery in treatment-refractory nontuberculous mycobacterial skin and soft tissue infections
35. Response
36. Clofazimine is a safe and effective alternative for rifampicin in Mycobacterium avium complex pulmonary disease treatment – outcomes of a randomized trial
37. The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
38. Monotherapy: Key cause of macrolide-resistant Mycobacterium avium complex disease
39. Understanding patients at risk of NTM-PD using a modified Delphi process
40. The potential role of drug transporters and amikacin modifying enzymes in M. avium
41. Disease caused by environmental mycobacteria
42. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease
43. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study
44. Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics
45. Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease
46. Mycobacterial (Skin) Infections
47. Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium aviumComplex Pulmonary Disease Treatment
48. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
49. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort
50. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.